Comparative Safety and Effectiveness of Apixaban Dosing in Patients With Atrial Fibrillation and Severe CKD

被引：0
|
作者：
Xu, Yunwen [1 ]
Chang, Alex R. [2 ]
Inker, Lesley A. [3 ]
McAdams-DeMarco, Mara [4 ]
Grams, Morgan [1 ,4 ]
Shin, Jung-Im [1 ]
机构：
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Geisinger Hlth, Danville, PA USA
[3] Tufts Med CTR, Boston, MA USA
[4] NYU, Grossman Sch Med & Langone Hlth, New York, NY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO896
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [31] Apixaban in Patients with Atrial Fibrillation
    Lynch, Donald R., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2362 - 2363
  • [32] Appropriateness of Apixaban Dosing to Prevent Stroke in Patients with Atrial Fibrillation: A Pilot Study
    Carlin, Stephanie
    Pickering, Jennifer
    Schulman, Sam
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2016, 69 (06): : 449 - 453
  • [33] Prospective Monitoring of Effectiveness and Safety of Apixaban in Older Adults with Atrial Fibrillation and Frailty
    Ko, D.
    Lin, K. J.
    Bessette, L. G.
    Lee, S.
    Cheng, S.
    Glynn, R. J.
    Kim, D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S225 - S225
  • [34] Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
    Jansson, M.
    Sjalander, S.
    Sjogren, V.
    Renlund, H.
    Norrving, B.
    Sjalander, A.
    THROMBOSIS RESEARCH, 2020, 185 : 135 - 141
  • [35] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [36] PROSPECTIVE MONITORING OF EFFECTIVENESS AND SAFETY OF APIXABAN IN OLDER ADULTS WITH ATRIAL FIBRILLATION AND FRAILTY
    Ko, Darae
    Lin, Kueiyu Joshua
    Bessette, Lily Gui
    Lee, Su Been
    Cheng, Susan
    Glynn, Robert J.
    Kim, Dae Hyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 160 - 160
  • [37] DIRECT COMPARISON OF DABIGATRAN, RIVAROXABAN, AND APIXABAN FOR EFFECTIVENESS AND SAFETY IN NONVALVULAR ATRIAL FIBRILLATION
    Noseworthy, Peter
    Yao, Xiaoxi
    Sangaralingham, Lindsey R.
    Abraham, Neena
    McBane, Robert
    Gersh, Bernard
    Shah, Nilay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 692 - 692
  • [38] Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
    Noseworthy, Peter A.
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    McBane, Robert D.
    Shah, Nilay D.
    CHEST, 2016, 150 (06) : 1302 - 1312
  • [39] Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation (vol 175, pg 1515, 2022)
    Lau, W. C. Y.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : 144 - 144
  • [40] Efficacy and safety of edoxaban in patients with atrial fibrillation (AF) and severe chronic kidney disease (CKD)
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N25 - N26
12345